Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,247Revenue $M219Net Margin (%)54.1Altman Z-Score50.7
Enterprise Value $M1,044EPS $2.8Operating Margin %60.8Piotroski F-Score6
P/E(ttm)15.6Beneish M-Score--Pre-tax Margin (%)60.8Higher ROA y-yY
Price/Book5.510-y EBITDA Growth Rate %--Quick Ratio26.0Cash flow > EarningsN
Price/Sales6.25-y EBITDA Growth Rate %--Current Ratio26.0Lower Leverage y-yY
Price/Free Cash Flow17.4y-y EBITDA Growth Rate %--ROA % (ttm)65.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)73.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M28.8ROIC % (ttm)822Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
NLNKJoel Greenblatt 2015-06-30 Add0.15%$36.55 - $56.87
$ 44.07-7%Add 48.51%1,244,856
NLNKFirst Eagle Investment 2015-06-30 Add0.03%$36.55 - $56.87
$ 44.07-7%Add 20.19%1,719,600
NLNKJoel Greenblatt 2015-03-31 Buy 0.35%$31.95 - $56.4
$ 44.072%New holding838,221
NLNKFirst Eagle Investment 2015-03-31 Add$31.95 - $56.4
$ 44.072%Add 1.73%1,430,700
NLNKFirst Eagle Investment 2014-03-31 Add0.02%$21.38 - $50.4
$ 44.0731%Add 28.35%1,161,805
NLNKFirst Eagle Investment 2013-09-30 Add0.01%$15.78 - $20.08
$ 44.07147%Add 21.32%778,354
NLNKFirst Eagle Investment 2013-06-30 Add0.02%$11.27 - $22.56
$ 44.07180%Add 95.04%641,554
NLNKFirst Eagle Investment 2013-03-31 Buy 0.01%$11.4 - $12.7
$ 44.07265%New holding328,939
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NLNK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ramsey William J.Quality Assurance Officer 2015-02-17Sell2,500$408.4view
Wiley BrianVP of Business Development 2015-02-17Sell10,000$40.078.21view
Link Charles J. Jr.Chairman of the Board and CEO 2015-02-05Sell20,000$32.4133.79view
Ramsey William J.Quality Assurance Officer 2015-01-23Sell2,500$408.4view
Link Charles J. Jr.Chairman of the Board and CEO 2015-01-07Sell20,000$37.9914.14view
Wiley BrianVP of Business Development 2015-01-02Sell20,000$40.337.51view
Link Charles J. Jr.Chairman of the Board and CEO 2014-12-04Sell20,000$37.8414.59view
HENNEMAN JOHN B IIIEVP, CFO 2014-11-25Buy5,000$34.3526.23view
Link Charles J. Jr.Chairman of the Board and CEO 2014-11-10Sell20,000$32.9431.63view
LINK GORDON H JRCFO 2014-10-24Sell2,500$40.397.35view

Quarterly/Annual Reports about NLNK:

News about NLNK:

Articles On GuruFocus.com
These Companies Show High Profit and Low Debt Jun 17 2015 
When A Stock Doubles, Don’t Trim It Automatically May 27 2015 
Greenblatt's Top Buys During First Quarter May 22 2015 
NewLink Genetics Corporation Offers a Risky Way to Generate Income Sep 11 2013 
Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 

More From Other Websites
NewLink Genetics Corp. Earnings Q2, 2015 Aug 27 2015
From Cancer To Ebola, NewLink Genetics Seeks Vaccines Aug 21 2015
NEWLINK GENETICS CORP Financials Aug 18 2015
NewLink Genetics Corp.: Price momentum supported by strong fundamentals Aug 18 2015
NEWLINK GENETICS CORP Files SEC form 10-Q, Quarterly Report Aug 06 2015
Only two Ebola cases reported in past week, but risks remain - WHO Aug 04 2015
Positive Developments Around Ebola Aug 03 2015
There's more to Merck's Ebola vaccine than money Jul 31 2015
Merck: Study shows potential Ebola vaccine has '100 percent efficacy' Jul 31 2015
Stocks Open Mixed, Dow Lags; Expedia, Amgen, NewLink Rising Jul 31 2015
CNBC update: Ebola vaccine Jul 31 2015
NEWLINK GENETICS CORP Files SEC form 8-K, Other Events Jul 31 2015
Vaccine Candidate Potentially Effective Against Ebola in Large Trial in Guinea Jul 31 2015
Q2 2015 NewLink Genetics Corp Earnings Release - Time Not Supplied Jul 31 2015
NewLink reports 2Q loss Jul 31 2015
NewLink reports 2Q loss Jul 31 2015
NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial... Jul 31 2015
NewLink Genetics to Host Its Second Quarter 2015 Earnings Conference Call on July 31, 2015 Jul 24 2015
NewLink Genetics Announces That Dr. Thomas Monath Received Award From American Veterinary... Jul 22 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)